Literature DB >> 7554977

Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.

B Xiao1, T Zeng, S Wu, H Sun, N Xiao.   

Abstract

In the present study 14 women after 6 years' use of levonorgestrel-releasing IUD were investigated for the changes of LH, progesterone (P), estradiol (E2), prolactin (PRL) and serum binding globulin (SHBG) in relation to the levonorgestrel levels throughout a segment of 26-40 days with the aim of comparing the hormonal profiles with those during the first year of use of Lng-IUD. Ultrasound scanning was used to follow the development of follicles along with the RIA measurement of hormones. The results of serum LH, P and E2 showed ovulation in 11 cases with either normal menstrual cycles (5 cases), prolonged or irregular cycles (4 cases) or with amenorrhea for 2-3 years (2 cases). One case showed insufficiency of luteal function and 2 cases showed anovulation but with follicular hyperactivity. Higher percentages of ovulatory cycles (78.5%) were found after 6 years of use. No case of complete suppression of ovulation was found. Anovulatory cycles only constituted 14.3%. Clinically, the development of follicles followed by ultrasound scanning further confirmed the hormonal findings. The persistent enlargement of follicles coincided with high levels of E2. After 6 years of use, the serum levels of levonorgestrel were still maintained at mean levels of 314.26 pmol/L and 470.63 pmol/L in the ovulatory and anovulatory groups, respectively. It is concluded that over two-thirds of the cases have ovulatory cycles after long-term use of Lng-IUD; the contraceptive effect is mainly due to its local action on the endometrium, with much less effect on the ovarian function.

Entities:  

Keywords:  Anovulation; Asia; Biology; China; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Demographic Factors; Developing Countries; Eastern Asia; Endocrine System; Endometrial Effects; Endometrium; Estradiol; Estrogens; Family Planning; Genitalia; Genitalia, Female; Gonadotropins; Gonadotropins, Pituitary; Hormones; Iud; Iud, Hormone Releasing; Levonorgestrel; Luteinizing Hormone; Ovarian Effects; Ovary; Physiology; Population; Population Dynamics; Progestational Hormones; Progesterone; Research Methodology; Research Report; Time Factors; Urogenital System; Uterus

Mesh:

Substances:

Year:  1995        PMID: 7554977     DOI: 10.1016/0010-7824(95)00102-g

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  11 in total

Review 1.  Challenges in the gynecologic care of premenopausal women with breast cancer.

Authors:  Jamie N Bakkum-Gamez; Shannon K Laughlin; Jani R Jensen; Clement O Akogyeram; Sandhya Pruthi
Journal:  Mayo Clin Proc       Date:  2011-02-09       Impact factor: 7.616

Review 2.  A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.

Authors:  F Sturridge; J Guillebaud
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

Review 3.  Choosing non-oral, long-acting reversible contraception.

Authors:  Mary Stewart; Deborah Bateson
Journal:  Aust Prescr       Date:  2016-10-01

Review 4.  Medical treatment of uterine leiomyoma.

Authors:  Mohamed Sabry; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2012-02-28       Impact factor: 3.060

5.  Levonorgestrel hormone releasing intrauterine system (Mirena) as a contraceptive in egg donors: case report.

Authors:  C Kailasam; V Akande; U D Gordon
Journal:  J Assist Reprod Genet       Date:  2005-03       Impact factor: 3.412

Review 6.  Estrogen- and progesterone-mediated structural neuroplasticity in women: evidence from neuroimaging.

Authors:  Eva Catenaccio; Weiya Mu; Michael L Lipton
Journal:  Brain Struct Funct       Date:  2016-02-20       Impact factor: 3.270

7.  Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.

Authors:  Tiina Backman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 8.  Contraception for cancer survivors.

Authors:  Eleanor Bimla Schwarz; Rachel Hess; James Trussell
Journal:  J Gen Intern Med       Date:  2009-11       Impact factor: 5.128

9.  Provider Attitudes, Preferences, and Practices Regarding Sexual and Reproductive Health for Adolescents and Young Adults With Sickle Cell Disease.

Authors:  Maayan Leroy-Melamed; Seethal Jacob; Marcia L Shew; Traci M Kazmerski
Journal:  J Adolesc Health       Date:  2021-07-20       Impact factor: 5.012

10.  Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium.

Authors:  Ashley S Felix; Mia M Gaudet; Carlo La Vecchia; Christina M Nagle; Xiao Ou Shu; Elisabete Weiderpass; Hans Olov Adami; Shirley Beresford; Leslie Bernstein; Chu Chen; Linda S Cook; Immaculata De Vivo; Jennifer A Doherty; Christine M Friedenreich; Susan M Gapstur; Dierdre Hill; Pamela L Horn-Ross; James V Lacey; Fabio Levi; Xiaolin Liang; Lingeng Lu; Anthony Magliocco; Susan E McCann; Eva Negri; Sara H Olson; Julie R Palmer; Alpa V Patel; Stacey Petruzella; Jennifer Prescott; Harvey A Risch; Lynn Rosenberg; Mark E Sherman; Amanda B Spurdle; Penelope M Webb; Lauren A Wise; Yong-Bing Xiang; Wanghong Xu; Hannah P Yang; Herbert Yu; Anne Zeleniuch-Jacquotte; Louise A Brinton
Journal:  Int J Cancer       Date:  2014-09-30       Impact factor: 7.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.